June 20, 2024 | DOL engagement, KOL Engagement, Pharma engagement, Pharma meeting, Pharma trends, Virtual Meeting, Virtual Pharma, insight gathering
Think outside the box with virtual engagements! Discover how creative asynchronous touchpoints can revolutionize your interactions. Explore everything from OLAs to treatment pathway profiling via a pharma-compliant virtual platform.
Explore the boundless potential of asynchronous touchpoints with our final tip in the series. Learn how creativity can redefine the scope and impact of your virtual interactions on the Impetus InSite Platform®.
10. Be Creative
Step beyond traditional advisory boards and team meetings. The Impetus InSite Platform® offers a versatile canvas for engaging participants in innovative ways. Whether it’s through Online Learning Activities (OLAs), journal clubs, case study discussions, post-(virtual) conference debriefs, patient journey mapping, or treatment pathway profiling, there’s a multitude of creative possibilities to explore. Embrace the flexibility of asynchronous touchpoints to craft unique and compelling engagement experiences that captivate and educate your participants.
This tip encourages you to think outside the box and discover new ways to leverage virtual tools for enhanced communication and deeper insight gathering.
For more creative strategies and insights into maximizing your virtual engagements, check out our blog: https://www.impetusdigital.com/2020/05/12/top-10-tips-for-optimizing-asynchronous-virtual-meetings/
Elevate your virtual engagements with Impetus Digital:
Stay connected for more creative ideas and updates:
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today’s diverse healthcare landscape. 7….
Join us for a look at the top-5 emerging virtual collaboration trends…
As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here’s another one to keep in…
Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care…
Here’s another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #10. Versatility! Another major advantage of using a virtual platform…
In the early lead-up to our client’s multi-center Rare Disease Phase 3 Clinical Trial, they first conducted an internal engagement planning Longitudinal Expert Engagement Plan™ (LEEP™) to conduct an informal…
Authentic patient engagement and insight-gathering are becoming must-haves in Pharma. However, multiple obstacles remain before patient-centricity becomes more than a buzzword. In our latest playbook, we take a deep dive…
Here’s another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #9. No More “White Space” Between Live Meetings Clearly, the…
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access.
Here’s another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #8. The Ease and Effectiveness of Sharing Knowledge and Data…
